Angell v. State

278 A.D.2d 776, 719 N.Y.S.2d 158, 2000 N.Y. App. Div. LEXIS 13940
CourtAppellate Division of the Supreme Court of the State of New York
DecidedDecember 28, 2000
DocketClaim No. 93189
StatusPublished
Cited by6 cases

This text of 278 A.D.2d 776 (Angell v. State) is published on Counsel Stack Legal Research, covering Appellate Division of the Supreme Court of the State of New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Angell v. State, 278 A.D.2d 776, 719 N.Y.S.2d 158, 2000 N.Y. App. Div. LEXIS 13940 (N.Y. Ct. App. 2000).

Opinion

Peters, J.

Appeal from an order of the Court of Claims (Hanifin, J.), entered March 13, 2000, which granted the State’s motion for summary judgment dismissing the claim.

Bryan K. Angell (hereinafter decedent) had a history of psychiatric institutionalization, including five admissions to Bassett Hospital in Otsego County between 1986 and 1988 and six to Binghamton Psychiatric Center (hereinafter BPC) in Broome County from 1987 through 1994. In August 1994, upon his transfer from Bassett Hospital to BPC, he was diagnosed with schizophrenia, epilepsy, tuberous sclerosis, seizure disorder and a history of suicide attempts. Following a neurological consult, a treatment plan was devised by physicians employed by BPC which included, inter alia, prescribed medication and psychiatric treatment. Such plan enabled decedent to exercise “grounds privileges” rather than being confined to his treatment unit.

In May 1995, decedent was accepted for placement in a group home and was on the waiting list for discharge. Although he was compliant with medication and was looking forward to increased privileges, angry outbursts, religious delusions and preoccupations were noted. When the frequency of his seizures increased, blood tests were performed to determine his medication levels and a referral was made to a neurologist when increased liver enzymes were noted. During such time, he was placed on closer supervision as a result of expressed frustration in not yet being discharged. Lalita Agneshwar, a clinical physician employed by BPC, testified that although her physical examination did not reveal any damage to his liver, she referred him to Arjun Patel, a physician at BPC, for further examination. Patel recommended a repeat of the liver profile. When one liver enzyme level was still elevated, he recommended that decedent’s seizure medication be temporarily discontinued. Agneshwar ultimately concluded, after speaking with decedent’s neurologist, that an increase in only one liver enzyme did not warrant a discontinuance of seizure medication and that the rise in such enzyme would not account for [777]*777behavioral changes. Agneshwar testified that she saw no reason, at that time, to further increase decedent’s supervision.

Decedent’s medical records detailed notations that by June 1995 he was becoming more distressed. On July 10, 1995, he was finally transferred to a “transitional living unit” to help him prepare for discharge. Upon his admission, he continued to have full grounds privileges, despite an increase in seizures, since this was viewed as a chronic medical condition. All physicians treating decedent, including his psychiatrist and Robert Grantham, the supervisor for the outpatient community service program at BPC, testified that it was not medically contraindicated to allow a patient who suffers from seizures to be discharged. Decedent’s records confirm that he was regularly taking his medication while under staff supervision and was experiencing no increasing problems other than disorientation one day prior to his death.

On June 14, 1995, decedent failed to arrive for his 5:00 p.m. medication. A search was undertaken and at 5:50 p.m. he was located in a closet; he was pronounced dead at 6:05 p.m. While the autopsy report revealed that the cause of death was unknown, it noted “that sudden death may occur in patients with tuberous sclerosis * * * usually due to arrhythmia. Sudden death may also be seen when focal myocardial lymphocytic infiltration is present. In summary, in view of the history of seizure disorder, death was probably due to recurrent, unwitnessed seizure activity.”

Claimant, as administrator of decedent’s estate,

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Voss v. Mandak Veterinary Servs.
2024 NY Slip Op 33398(U) (New York Supreme Court, Saratoga County, 2024)
Matney v. Boyle
2024 NY Slip Op 30001 (New York Supreme Court, Saratoga County, 2024)
Holland v. Cayuga Med. Ctr. at Ithaca, Inc.
2021 NY Slip Op 03896 (Appellate Division of the Supreme Court of New York, 2021)
Lomonaco v. United Health Services Hospitals, Inc.
16 A.D.3d 958 (Appellate Division of the Supreme Court of New York, 2005)
Jacobs v. Newton
1 Misc. 3d 171 (Civil Court of the City of New York, 2003)
Carter v. State
284 A.D.2d 810 (Appellate Division of the Supreme Court of New York, 2001)

Cite This Page — Counsel Stack

Bluebook (online)
278 A.D.2d 776, 719 N.Y.S.2d 158, 2000 N.Y. App. Div. LEXIS 13940, Counsel Stack Legal Research, https://law.counselstack.com/opinion/angell-v-state-nyappdiv-2000.